“Advances in Nanotechnology-Enabled Drug Delivery for Combining PARP Inhibitors and Immunotherapy in Advanced Ovarian Cancer”. 2024. Biomolecules and Biomedicine 24 (2): 230–237. https://doi.org/10.17305/bb.2023.9757.